Wolfgang Miesbach: Highlighting a Critical and Overlooked Dimension of Rare Bleeding Disorders in Women at EAHAD 2026
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”Rare Bleeding Disorders in Women — Still Underdiagnosed, Still Undertreated.
An excellent presentation by Saskia Schols at this year’s EAHAD congress highlighted a critical and often overlooked dimension of Rare Bleeding Disorders (RBDs): the disproportionate burden on women and girls.
Bleeding phenotype across RBDs
From fibrinogen disorders to FVII, FX, FXI and FXIII deficiency, the most common symptoms include mucocutaneous bleeding, epistaxis, postoperative bleeding — and consistently: heavy menstrual bleeding (HMB) and postpartum haemorrhage (PPH).
Even mild fibrinogen disorders (hypofibrinogenemia, dysfibrinogenemia) carry a bleeding grade severity ≥1 in the majority of patients.
A diagnostic gap that cannot be ignored
- Median age at RBD diagnosis: 28 years — with a diagnostic delay of ~14 years from menarche
- Women/girls may have normal PT and APTT — standard tests miss the bleeding
- Approximately 80% required treatment; 30% absent from work/school >2×/year
Using the right bleeding assessment tool — ISTH BAT, EN-RBD BSS, or Bleeding Severity Score — for the right patient makes all the difference.
Women with RBDs deserve earlier diagnosis and tailored care.
Thank you Saskia for this important message!”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: Don’t Let EDTA Fool You – When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 22:03Erin VanDyke: A Journey Through VTE Leadership and Healthcare Transformation
-
Jun 23, 2026, 20:30Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV
-
Jun 23, 2026, 19:20Simos Kokkovos: 1st Ever Mobile Stroke Unit in Greece is on its way to Metropolitan Hospital
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation